PlatinumRx, a healthcare startup, has successfully secured $800,000 in funding during its seed round. The investment was led by India Quotient, with the participation of various notable angel investors.

PlatinumRx intends to use the funds to expand its warehousing and distribution network, improve its nationwide presence, and broaden its range of products, as stated in a recent press release.

Ashutosh Pandey and Piyush Kumar established PlatinumRx with the goal of revolutionizing the method through which chronic patients obtain necessary medications. The company carefully selects and provides alternatives from reputable brands such as Cipla, Abbott, Alkem, and others. PlatinumRx assists individuals in locating precise substitute medications that contain identical salt composition, strength, and efficacy.

PlatinumRx offers delivery services to over 20,000 pincodes, ensuring delivery within 2-3 days. Additionally, same-day delivery is available in Bengaluru. The company has established partnerships with various old age homes and rehabilitation centers in the electronic city area.

Gagan Goyal,General Partner at India Quotient said,"With rising diabetes and blood pressure-related ailments, coupled with soaring monthly medicine expenses, cost reduction for all chronic illnesses without compromising efficacy is crucial."

Founded by Anand Lunia and Madhukar Sinha in 2012, India Quotient unveiled its fourth fund totaling $80 million in February 2021. Few of the notable of its investorsare WebEngage, Dhiwise, Vyapar, Pagarbook, Fleetx, Powerplay, Brands.live, and GoComet.